Prathyusha Durabaibu
Net worth: 614 639 $ as of 2026-05-30
Net worth: 614 639 $ as of 2026-05-30
Ms. Prathyusha Durabaibu is an Independent Director at Organogenesis Holdings, Inc. She is on the Board of Directors at Organogenesis Holdings, Inc. Ms. Durabaibu was previously employed as a Principal Financial Officer by Sangamo Therapeutics, Inc. and a Controller by Pacific Biosciences of California, Inc. She received her undergraduate degree from Oxford Brookes University and an MBA from San Jose State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-09 | 198,219 ( 0.15% ) | 509 423 $ | 2026-05-30 | |
| 2026-01-21 | 482,645 ( 0.12% ) | 105 217 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Director/Board Member | 2021-11-18 |
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 2026-02-02 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Comptroller/Controller/Auditor | 2019-02-28 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Select your edition
All financial news and data tailored to specific country editions